As a leading early-stage investor, WRF works with entrepreneurs, research institutions, other investors and industry partners to transform great ideas into successful Washington-based businesses. WRF has invested in more than 130 local startups since 1996.
WRF Capital is the investment vehicle for Washington Research Foundation. We invest approximately $5 million annually in startup companies based in Washington, with a focus on spinouts from nonprofit research institutions in our state: UW, WSU, Fred Hutch and ISB, among many others. We invest across pre-seed to Series A companies, spanning life sciences and enabling technologies. Since 1996 we have invested in more than 130 local startups.
Our initial investments range from $100,000 to $2 million, with reserves for follow-on financings. Through early-stage investing, WRF Capital enables technologies developed by Washington-based companies to reach the market. We understand the distinctive challenges of commercializing new technologies and help other investors through our proven track record of thorough due diligence and selective investments.
We are often the first money in, and we partner with angels and VCs over early and later rounds. We can lead investments, syndicating with firms that add value to the team and technology.
Contact Us
If your business or investment opportunity sounds like a good fit for WRF Capital, please contact us at investments@wrfcapital.com.
We prefer to invest in startups developing technologies with life sciences applications. Our portfolio includes companies in the following areas:
Life Sciences
Includes biotechnology, pharmaceuticals, medical devices and digital health
Information Technology
Includes enterprise software and internet-based solutions that offer innovation with near- and long-term potential
Physical Sciences
Includes advanced materials and scientific instrumentation
Our startup companies support our mission. Their successes create products and services that improve the lives of the public.
Our team understands the unique challenges of commercializing new technology, and the risks inherent in advancing it.